All stock lists
Cogent Biosciences, Inc. (NASDAQ:COGT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
30.56-0.65 (-2.08%)
Insider Score
––Not scored
COGT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
COGT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 1.16 M | 1.18 M | 0.00 | 1.16 M | 0.00 |
| Gross Profit | 0.00 | -1.16 M | -1.18 M | 0.00 | -1.16 M | 0.00 |
| SG&A Expense | 31.83 M | 28.24 M | 23.93 M | 14.37 M | 13.38 M | 11.90 M |
| R&D Expense | 70.81 M | 75.36 M | 74.38 M | 68.99 M | 61.05 M | 63.03 M |
| Operating Expenses | 102.64 M | 102.45 M | 98.32 M | 83.36 M | 74.42 M | 74.93 M |
| Operating Income | -102.64 M | -103.61 M | -99.49 M | -83.36 M | -75.58 M | -74.93 M |
| Pretax Income | -96.41 M | -97.35 M | -102.49 M | -80.93 M | -73.53 M | -71.99 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -96.41 M | -97.35 M | -102.49 M | -80.93 M | -73.53 M | -71.99 M |
| EPS (Basic) | -0.52 | -0.57 | -0.64 | -0.58 | -0.65 | -0.63 |
| EPS (Diluted) | -0.52 | -0.57 | -0.64 | -0.58 | -0.65 | -0.63 |
| Shares Outstanding | 171.01 M | 170.77 M | 160.98 M | 139.83 M | 113.93 M | 113.86 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.